APO IMA 400 Pill: orange , capsule/oblong, 17mm
The pill with imprint APO IMA 400 (Orange, Capsule/Oblong1) has been identified as Imatinib Mesylate 400 mg and is used for Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Dermatofibrosarcoma Protuberans, and Gastrointestinal Stromal Tumor. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.
Images for APO IMA 400


Imatinib Mesylate
- Imprint
- APO IMA 400
- Strength
- 400 mg
- Color
- Orange
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
magnesium stearate,
hypromellose 2910 (5 mPa.s),
hydroxypropyl cellulose (type l),
ferric oxide red,
ferric oxide yellow,
polyethylene glycol 8000
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
42291-0352 (Discontinued) | AvKare, Inc. |
60505-2901 | Apotex Corp. |
See also:
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.